Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice

QR Code

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice

Bibliographic Details
Main Authors:	Barron, A., Verdile, Giuseppe, Taddei, K., Martins, R.
Format:	Journal Article
Published:	The Endocrine Society 2010
Online Access:	http://hdl.handle.net/20.500.11937/34006

Similar Items

The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

Limitations of the human Chorionic Gonadotropin (hCG) assay in the diagnosis of gestational trophoblastic disease
by: Rusman, Zety Wizana, et al.
Published: (2022)

Limitations of the human chorionic gonadotropin hCG assay in the diagnosis of gestational trophoblastic disease
by: Rusman, Zety Wizana, et al.
Published: (2022)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

Early second trimester hCG of maternal serum as predictor marker for pregnancy induced hypertension
by: Munirah Md Mansor,, et al.
Published: (2018)

The influence of additional administration of human chorionic gonadotropin (hCG) following intrauterine insemination on the clinical pregnancy outcome: a hospital-based review
by: Ng, BK, et al.
Published: (2012)

Unruptured left cornual pregnancy with a high serum beta-hCG: a case report
by: Nirmala CK,, et al.
Published: (2011)

Effects of latrepirdine on Aß clearance, neurotoxicity and aggregation
by: Martins, R., et al.
Published: (2010)

Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019)

Influence of coding variability in APP-Aß metabolism genes in sporadic Alzheimer's disease
by: Sassi, C., et al.
Published: (2016)

Plasma Aß42 correlates positively with increased body fat in healthy individuals
by: Balakrishnana, K., et al.
Published: (2005)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Latrepirdine enhances Aß degradation in yeast via an autophagic pathway
by: Bharadwaj, Prashant, et al.
Published: (2010)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of ?-secretase activity
by: Nik, S., et al.
Published: (2015)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

Oligomerization and toxicity of Aß fusion proteins
by: Caine, J., et al.
Published: (2011)

Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction
by: Foster, Jonathan, et al.
Published: (2008)

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
by: Goozee, K., et al.
Published: (2015)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

Modulation of Amyloid Beta (Aß) Structure and Toxicity by a Dairy-derived Peptide Product
by: Bennett, L., et al.
Published: (2010)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

The structure and function of Alzheimer's gamma secretase enzyme complex
by: Krishnaswamy, S., et al.
Published: (2009)

An investigation into CG Principles and Firm Performance
by: Ooi, Kai Yong
Published: (2017)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)

Assessing genetic overlap of Alzheimer’s disease with type 2 diabetes
by: Adewuyi, Emmanuel, et al.
Published: (2025)

The Guinea Pig as a Model for Sporadic Alzheimer’s Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes
by: Sharman, Matthew, et al.
Published: (2013)

The algorithms of Broyden-CG for unconstrained optimization problems
by: Ibrahim, Mohd Asrul Hery, et al.
Published: (2014)

The CG-BFGS method for unconstrained optimization problems
by: Ibrahim, Mohd Asrul Hery, et al.
Published: (2013)

Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?
by: Sharman, M., et al.
Published: (2019)